These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6254875)

  • 1. Lymphocyte-derived chemotactic factor synthesis in initial genital herpesvirus infection: correlation with lymphocyte transformation.
    Rattray MC; Peterman GM; Altman LC; Corey L; Holmes KK
    Infect Immun; 1980 Oct; 30(1):110-6. PubMed ID: 6254875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular immune response in genital herpes simplex virus infection.
    Corey L; Reeves WC; Holmes KK
    N Engl J Med; 1978 Nov; 299(18):986-91. PubMed ID: 211414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
    O'Reilly RJ; Chibbaro A; Anger E; Lopez C
    J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
    Sheridan JF; Aurelian L
    Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of chemotactic factor and lymphotoxin by human leukocytes stimulated with Herpes simplex virus.
    Rosenberg GL; Snyderman R; Notkins AL
    Infect Immun; 1974 Jul; 10(1):111-5. PubMed ID: 4366917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of lymphocyte transformation response to herpes simplex virus infection by acyclovir therapy.
    Lafferty WE; Brewer LA; Corey L
    Antimicrob Agents Chemother; 1984 Dec; 26(6):887-91. PubMed ID: 6098221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated cytotoxicity in recurrent herpes simplex virus infections in man.
    Reichman RC; Dolin R; Vincent MM; Fauci AS
    Proc Soc Exp Biol Med; 1977 Sep; 155(4):571-6. PubMed ID: 197538
    [No Abstract]   [Full Text] [Related]  

  • 8. Lymphocyte transformation and interferon production in human mononuclear cell microcultures for assay of cellular immunity to herpes simplex virus.
    Haahr S; Rasmussen L; Merigan TC
    Infect Immun; 1976 Jul; 14(1):47-54. PubMed ID: 181328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of lymphokines and interferon by immune cells involved in recovery of mice from herpes simplex virus type 2 hepatitis.
    Iannello D; Mogensen SC
    Immunobiology; 1985 May; 169(4):412-23. PubMed ID: 2408997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs.
    Donnenberg AD; Bell RB; Aurelian L
    Cell Immunol; 1980 Dec; 56(2):526-39. PubMed ID: 6258811
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.
    Donnenberg AD; Chaikof E; Aurelian L
    Infect Immun; 1980 Oct; 30(1):99-109. PubMed ID: 6254886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of T lymphocytes in cellular immune responses during herpes simplex virus infection in humans.
    Rasmussen L; Merigan TC
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3957-61. PubMed ID: 308659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine production by human milk lymphocytes.
    Keller MA; Kidd RM; Bryson YJ; Turner JL; Carter J
    Infect Immun; 1981 May; 32(2):632-6. PubMed ID: 6166559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sero-epidemiology of type--2 (genital) herpes simplex virus infection in Ibadan.
    Adelusi B; Fabiyi A; Osunkoy BO
    J Hyg Epidemiol Microbiol Immunol; 1978; 22(4):453-9. PubMed ID: 224105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
    Zaia JA; Palmer EL; Feorino PM
    J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)].
    Wassilew SW; Koch I
    Arch Dermatol Res; 1978 Aug; 262(3):267-74. PubMed ID: 214045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonvirion antigens produced by herpes simplex viruses 1 and 2.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of guinea pigs against primary and recurrent genital herpes infections by immunization with live heterologous or homologous Herpes simplex virus: implications for a herpes virus vaccine.
    Scriba M
    Med Microbiol Immunol; 1978 Nov; 166(1-4):63-9. PubMed ID: 214688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte transformation for the detection of herpesvirus-induced tumor-associated antigens.
    Harris LF; Hamparian VV; Young EA; Hughes JH
    Cancer Res; 1979 Oct; 39(10):3996-4002. PubMed ID: 225013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of cellular immunity in the infection with herpes simplex virus.
    Kirchner H; Schröder CH; Zawatzky R; Kleinicke C
    Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):149-58. PubMed ID: 228888
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.